Nasrin Ahmadinejad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nasrin Ahmadinejad has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Arvin Arian
Medical Imaging Center, Cancer Research Institute, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
4 shared publications Nahid Sedighi
Medical Imaging Center, Cancer Research Institute, Imam Khomeini Hospital Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences (TUMS), Tehran, Iran
3 shared publicationsAli Zare Dehnavi
Advanced Diagnostic and Interventional Radiology Research Center, Tehran University of Medical Sciences, Tehran, Iran
2 shared publicationsAmir Hassan Mohajeri
Islamic Azad University Tehran Medical Science, Tehran, Iran
2 shared publications- Behnaz Moradi
Department of Radiology, Yas Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications Hedieh Akbari
Tehran University of Medical Sciences, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (7)
Second‐Look Ultrasonography for Evaluating BIRADS 3 and 4 Non Mass‐Enhancement: A Cross‐Sectional Study
Background and Aims: Breast MRI is a highly sensitive imaging modality for assessing suspected breast lesions; nevertheless, its specificity is poor, ranging from 40% to 80% in various studies. Second‐look ultrasound (SLUS) is a tool for the validation of MRI‐identified breast abnormalities. This study aimed to assess the role of SLUS as a complementary method for evaluating suspicious non mass‐enhancement (NME) on breast MRI. Methods: Fifty patients with 52 non‐mass enhancing lesions, classified as BIRADS 3 or 4 on MRI by an expert breast radiologist, were rechecked by SLUS. The relationship between age, breast cancer history, MRI indication, imaging features, and BIRADS classification of the lesions with the sonographic detection rate and pathology findings was analyzed. Results: Out of 52 lesions, 23 were identified on SLUS, 21 patients referred to biopsy. Seven out of 21 biopsies had malignant pathologies. Age less than 40 years, pathological breast discharge, and BIRADS‐MRI 4 had a positive relationship with the identification on SLUS. Five of 29 lesions that had no sonographic findings were referred to stereotactic biopsy due to suspicious findings on mammography, and four were malignant on pathology. The only variable that showed a significant relationship with the lesion malignancy was the BIRADS category on MRI. Conclusion: NMEs with BIRADS 4 on MRI were more detectable on SLUS than BIRADS‐MRI 3. If detected, ultrasound could not downgrade the BIRADS category of the lesions or exempt them from biopsy.
- 30 June 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (7)
Open AccessSecond‐Look Ultrasonography for Evaluating BIRADS 3 and 4 Non Mass‐Enhancement: A Cross‐Sectional Study
Background and Aims: Breast MRI is a highly sensitive imaging modality for assessing suspected breast lesions; nevertheless, its specificity is poor, ranging from 40% to 80% in various studies. Second‐look ultrasound (SLUS) is a tool for the validation of MRI‐identified breast abnormalities. This study aimed to assess the role of SLUS as a complementary method for evaluating suspicious non mass‐enhancement (NME) on breast MRI. Methods: Fifty patients with 52 non‐mass enhancing lesions, classified as BIRADS 3 or 4 on MRI by an expert breast radiologist, were rechecked by SLUS. The relationship between age, breast cancer history, MRI indication, imaging features, and BIRADS classification of the lesions with the sonographic detection rate and pathology findings was analyzed. Results: Out of 52 lesions, 23 were identified on SLUS, 21 patients referred to biopsy. Seven out of 21 biopsies had malignant pathologies. Age less than 40 years, pathological breast discharge, and BIRADS‐MRI 4 had a positive relationship with the identification on SLUS. Five of 29 lesions that had no sonographic findings were referred to stereotactic biopsy due to suspicious findings on mammography, and four were malignant on pathology. The only variable that showed a significant relationship with the lesion malignancy was the BIRADS category on MRI. Conclusion: NMEs with BIRADS 4 on MRI were more detectable on SLUS than BIRADS‐MRI 3. If detected, ultrasound could not downgrade the BIRADS category of the lesions or exempt them from biopsy.
- Open Access
- 31 July 2025
- Published by Wiley in Cancer Reports
- Vol. 8 (8) , e70288
Sonographic Correlations With Histological Grade and Biomarker Profiles in Breast Invasive Ductal Carcinoma
Background: Invasive ductal carcinoma (IDC), the most common breast cancer subtype, exhibits significant heterogeneity, limiting traditional prognostic markers. Molecular profiles improve precision, but imaging features may also reflect tumor biology.Aims: This study evaluates the predictive potential and clinical applicability of ultrasound features for determining tumor grade and molecular profiles in IDC.Methods and Results: A blinded radiologist retrospectively analyzed 109 IDC cases using the American College of Radiology (ACR) Breast Imaging Reporting and Data System (BI‐RADS) classification, evaluating ultrasound features such as lesion shape, margins, orientation, echo pattern, calcifications, vascularity, and lymph node involvement. Tumors were graded histologically (Scarff‐Bloom‐Richardson system) as low (grades 1 and 2) or high (grade 3). Immunohistochemistry determined estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki‐67 status. ER and PR positivity were defined as > 10% nuclear staining, HER2 graded on a 0–3+ scale, and Ki‐67 positivity as ≥ 10% staining. Statistical analyses, including logistic and linear regression, examined correlations between ultrasound features and histological/molecular profiles. Among 109 women (mean age 48.4 ± 12.5 years), the mean tumor length and width were 21.83 ± 11.22 mm and 15.3 ± 6.97 mm, respectively. Histopathological grading revealed that grade 2 tumors were predominant (51%), while grade 1 and grade 3 tumors were observed in 25% and 24% of cases, respectively. ER and PR positivity were observed in 76.4% and 67.6% of cases, respectively. High‐grade tumors were significantly associated with ER and PR negativity (p‐value < 0.05). Ultrasound features associated with high‐grade tumors included larger tumor length (p‐value = 0.029). ER positive tumors had smaller axillary lymph nodes (p‐value < 0.05). Likewise, PR positive tumors exhibited smaller suspicious axillary lymph nodes compared to PR negative cases (p‐value = 0.004).Conclusion: Sonographic features may correlate with histological grades and hormone receptor statuses in breast IDC, suggesting that ultrasound could aid in predictive assessment.
- 31 July 2025
- Published by Wiley in Cancer Reports
- Vol. 8 (8) , e70288
Open AccessSonographic Correlations With Histological Grade and Biomarker Profiles in Breast Invasive Ductal Carcinoma
Background: Invasive ductal carcinoma (IDC), the most common breast cancer subtype, exhibits significant heterogeneity, limiting traditional prognostic markers. Molecular profiles improve precision, but imaging features may also reflect tumor biology.Aims: This study evaluates the predictive potential and clinical applicability of ultrasound features for determining tumor grade and molecular profiles in IDC.Methods and Results: A blinded radiologist retrospectively analyzed 109 IDC cases using the American College of Radiology (ACR) Breast Imaging Reporting and Data System (BI‐RADS) classification, evaluating ultrasound features such as lesion shape, margins, orientation, echo pattern, calcifications, vascularity, and lymph node involvement. Tumors were graded histologically (Scarff‐Bloom‐Richardson system) as low (grades 1 and 2) or high (grade 3). Immunohistochemistry determined estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki‐67 status. ER and PR positivity were defined as > 10% nuclear staining, HER2 graded on a 0–3+ scale, and Ki‐67 positivity as ≥ 10% staining. Statistical analyses, including logistic and linear regression, examined correlations between ultrasound features and histological/molecular profiles. Among 109 women (mean age 48.4 ± 12.5 years), the mean tumor length and width were 21.83 ± 11.22 mm and 15.3 ± 6.97 mm, respectively. Histopathological grading revealed that grade 2 tumors were predominant (51%), while grade 1 and grade 3 tumors were observed in 25% and 24% of cases, respectively. ER and PR positivity were observed in 76.4% and 67.6% of cases, respectively. High‐grade tumors were significantly associated with ER and PR negativity (p‐value < 0.05). Ultrasound features associated with high‐grade tumors included larger tumor length (p‐value = 0.029). ER positive tumors had smaller axillary lymph nodes (p‐value < 0.05). Likewise, PR positive tumors exhibited smaller suspicious axillary lymph nodes compared to PR negative cases (p‐value = 0.004).Conclusion: Sonographic features may correlate with histological grades and hormone receptor statuses in breast IDC, suggesting that ultrasound could aid in predictive assessment.
- Open Access
- 1 July 2024
- Published by Apex Publishing in International Journal of Radiation Research
- Vol. 22 (3) , 749-755
The value of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in the prediction of neoadjuvant chemotherapy response in breast cancer: A Meta-Analysis
Background: The Breast dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) is utilized for screening breast cancer (BC) in women with a total lifetime BC risk of greater than 20-25%. This study aimed to assess the DCE-MRI value in predicting response to neoadjuvant chemotherapy (NAC) in BC patients. Materials and Methods: International databases, ...
- 1 July 2024
- Published by Apex Publishing in International Journal of Radiation Research
- Vol. 22 (3) , 749-755
Open AccessThe value of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in the prediction of neoadjuvant chemotherapy response in breast cancer: A Meta-Analysis
Background: The Breast dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) is utilized for screening breast cancer (BC) in women with a total lifetime BC risk of greater than 20-25%. This study aimed to assess the DCE-MRI value in predicting response to neoadjuvant chemotherapy (NAC) in BC patients. Materials and Methods: International databases, ...
- Open Access
- 1 May 2024
- Published by Archives of Breast Cancer in Archives of Breast Cancer
- Vol. 11 (2) , 126-137
Assessing Magnetic Resonance Imaging Sensitivity and Specificity for Detecting Occult Nipple-Areolar Complex Malignancy in Nipple-Sparing Mastectomy Candidates: A Systematic Review and Meta-Analysis
Background: Approximately 8% of breast cancers originate within the central ducts near the nipple-areolar complex(NAC), which has revealed higher rates of occult involvement than previously thought. Precise preoperative imaging to assess NAC and subjacent tumor involvement has become critical to identify candidates for nipple-sparing mastectomy (NSM) while ensuring oncological safety. The aim of our study is to determine whether Magnetic Resonance Imaging (MRI) could be used for the detection of subtle neoplastic infiltration. Method: Electronic databases including PubMed, Scopus, Web of Science, and EMBASE were systematically searched to identify all relevant studies published before 2024 on diagnostic performance of MRI in malignant extension to the nipple. The keywords included MRI, NAC, breast cancer, NSM, True Positive (TP), True Negative (TN), False Positive (FP), False Negative (FN) were extracted for analysis. Finally, 5 articles were selected for our meta-analysis. STATA version 15 was used to analysis data. Result: Our meta-analysis showed a pooled sensitivity of 85%(95% CI: 77%-91%)with low heterogeneity(I2 = 00.00%), and a pooled specificity of 82% (95% CI: 49%- 95%), with significant heterogeneity(I2 = 98%). The pooled positive diagnostic likelihood ratio(pDLR) was 4.6(95% CI: 1.3-16.6, I2 = 96.66%), and the negative diagnostic likelihood ratio(nDLR) was 0.18(95% CI: 0.10-0.33, I2 = 50.06%). Conclusion: Diagnostic MRI characteristics such as NAC enhancement, non-mass enhancement (NME) type, mass size (greater than 20 mm), and tumor-to-nipple distance (TND) were assocaited with the presence of NAC involement. Because of high diagnostic accuracy, MRI imaging can be used as a helpful tool for NAC diagnosis.
- 1 May 2024
- Published by Archives of Breast Cancer in Archives of Breast Cancer
- Vol. 11 (2) , 126-137
Open AccessAssessing Magnetic Resonance Imaging Sensitivity and Specificity for Detecting Occult Nipple-Areolar Complex Malignancy in Nipple-Sparing Mastectomy Candidates: A Systematic Review and Meta-Analysis
Background: Approximately 8% of breast cancers originate within the central ducts near the nipple-areolar complex(NAC), which has revealed higher rates of occult involvement than previously thought. Precise preoperative imaging to assess NAC and subjacent tumor involvement has become critical to identify candidates for nipple-sparing mastectomy (NSM) while ensuring oncological safety. The aim of our study is to determine whether Magnetic Resonance Imaging (MRI) could be used for the detection of subtle neoplastic infiltration. Method: Electronic databases including PubMed, Scopus, Web of Science, and EMBASE were systematically searched to identify all relevant studies published before 2024 on diagnostic performance of MRI in malignant extension to the nipple. The keywords included MRI, NAC, breast cancer, NSM, True Positive (TP), True Negative (TN), False Positive (FP), False Negative (FN) were extracted for analysis. Finally, 5 articles were selected for our meta-analysis. STATA version 15 was used to analysis data. Result: Our meta-analysis showed a pooled sensitivity of 85%(95% CI: 77%-91%)with low heterogeneity(I2 = 00.00%), and a pooled specificity of 82% (95% CI: 49%- 95%), with significant heterogeneity(I2 = 98%). The pooled positive diagnostic likelihood ratio(pDLR) was 4.6(95% CI: 1.3-16.6, I2 = 96.66%), and the negative diagnostic likelihood ratio(nDLR) was 0.18(95% CI: 0.10-0.33, I2 = 50.06%). Conclusion: Diagnostic MRI characteristics such as NAC enhancement, non-mass enhancement (NME) type, mass size (greater than 20 mm), and tumor-to-nipple distance (TND) were assocaited with the presence of NAC involement. Because of high diagnostic accuracy, MRI imaging can be used as a helpful tool for NAC diagnosis.
- Open Access
- 18 March 2024
- Published by Brieflands in Iranian Journal of Radiology
- Vol. 20 (4)
Role of Tomosynthesis in Determining the BI-RADS Score of Individuals with Indeterminate Mammography Results
Background: Tomosynthesis, despite its potential to produce superior images compared to mammography for Breast Imaging-Reporting and Data System (BI-RADS) scoring, has not yet been widely adopted. This is likely due to a combination of insufficient data and a scarcity of expertise in this area. Objectives: In this study, we aimed to evaluate the potential benefits of tomosynthesis for patients with indeterminate BI-RADS results from full-field digital mammography (FFDM). Specifically, we sought to determine whether this method could clarify ambiguous BI-RADS scores. Patients and Methods: This cross-sectional study involved 386 female patients, with an average age of 44.7 ± 7.9 years. The study included all patients who were admitted to a referral center for breast radiology during 2019 - 2020 and underwent both FFDM and tomosynthesis within a short interval. The purpose of performing tomosynthesis was to assess its additional benefits over FFDM. The collected data was input into SPSS version 20 for analysis. A P-value of less than 0.05 was deemed statistically significant. Results: Out of 152 patients who initially had indeterminate findings in mammography (BI-RADS score of 0), only one patient (0.7%) remained indeterminate after tomosynthesis. This implies that tomosynthesis was able to clarify the BI-RADS scores for 99.3% of patients with previously indeterminate scores. Specifically, out of these 151 patients, 81 were scored as BI-RADS 2, 45 as BI-RADS 3, 19 as BI-RADS 4, and six as BI-RADS 5. Conclusion: Tomosynthesis has the capability to clarify unclear FFDM BI-RADS scores in over 99% of cases. This suggests that it could serve as the primary supplementary imaging technique for cases with indeterminate BI-RADS scores.
- 18 March 2024
- Published by Brieflands in Iranian Journal of Radiology
- Vol. 20 (4)
Open AccessRole of Tomosynthesis in Determining the BI-RADS Score of Individuals with Indeterminate Mammography Results
Background: Tomosynthesis, despite its potential to produce superior images compared to mammography for Breast Imaging-Reporting and Data System (BI-RADS) scoring, has not yet been widely adopted. This is likely due to a combination of insufficient data and a scarcity of expertise in this area. Objectives: In this study, we aimed to evaluate the potential benefits of tomosynthesis for patients with indeterminate BI-RADS results from full-field digital mammography (FFDM). Specifically, we sought to determine whether this method could clarify ambiguous BI-RADS scores. Patients and Methods: This cross-sectional study involved 386 female patients, with an average age of 44.7 ± 7.9 years. The study included all patients who were admitted to a referral center for breast radiology during 2019 - 2020 and underwent both FFDM and tomosynthesis within a short interval. The purpose of performing tomosynthesis was to assess its additional benefits over FFDM. The collected data was input into SPSS version 20 for analysis. A P-value of less than 0.05 was deemed statistically significant. Results: Out of 152 patients who initially had indeterminate findings in mammography (BI-RADS score of 0), only one patient (0.7%) remained indeterminate after tomosynthesis. This implies that tomosynthesis was able to clarify the BI-RADS scores for 99.3% of patients with previously indeterminate scores. Specifically, out of these 151 patients, 81 were scored as BI-RADS 2, 45 as BI-RADS 3, 19 as BI-RADS 4, and six as BI-RADS 5. Conclusion: Tomosynthesis has the capability to clarify unclear FFDM BI-RADS scores in over 99% of cases. This suggests that it could serve as the primary supplementary imaging technique for cases with indeterminate BI-RADS scores.
- Open Access
- 18 March 2024
- Published by Brieflands in Iranian Journal of Radiology
- Vol. 20 (4)
Role of Tomosynthesis in Determining the BI-RADS Score of Individuals with Indeterminate Mammography Results
Background: Tomosynthesis, despite its potential to produce superior images compared to mammography for Breast Imaging-Reporting and Data System (BI-RADS) scoring, has not yet been widely adopted. This is likely due to a combination of insufficient data and a scarcity of expertise in this area. Objectives: In this study, we aimed to evaluate the potential benefits of tomosynthesis for patients with indeterminate BI-RADS results from full-field digital mammography (FFDM). Specifically, we sought to determine whether this method could clarify ambiguous BI-RADS scores. Patients and Methods: This cross-sectional study involved 386 female patients, with an average age of 44.7 ± 7.9 years. The study included all patients who were admitted to a referral center for breast radiology during 2019 - 2020 and underwent both FFDM and tomosynthesis within a short interval. The purpose of performing tomosynthesis was to assess its additional benefits over FFDM. The collected data was input into SPSS version 20 for analysis. A P-value of less than 0.05 was deemed statistically significant. Results: Out of 152 patients who initially had indeterminate findings in mammography (BI-RADS score of 0), only one patient (0.7%) remained indeterminate after tomosynthesis. This implies that tomosynthesis was able to clarify the BI-RADS scores for 99.3% of patients with previously indeterminate scores. Specifically, out of these 151 patients, 81 were scored as BI-RADS 2, 45 as BI-RADS 3, 19 as BI-RADS 4, and six as BI-RADS 5. Conclusion: Tomosynthesis has the capability to clarify unclear FFDM BI-RADS scores in over 99% of cases. This suggests that it could serve as the primary supplementary imaging technique for cases with indeterminate BI-RADS scores.
- 18 March 2024
- Published by Brieflands in Iranian Journal of Radiology
- Vol. 20 (4)
Open AccessRole of Tomosynthesis in Determining the BI-RADS Score of Individuals with Indeterminate Mammography Results
Background: Tomosynthesis, despite its potential to produce superior images compared to mammography for Breast Imaging-Reporting and Data System (BI-RADS) scoring, has not yet been widely adopted. This is likely due to a combination of insufficient data and a scarcity of expertise in this area. Objectives: In this study, we aimed to evaluate the potential benefits of tomosynthesis for patients with indeterminate BI-RADS results from full-field digital mammography (FFDM). Specifically, we sought to determine whether this method could clarify ambiguous BI-RADS scores. Patients and Methods: This cross-sectional study involved 386 female patients, with an average age of 44.7 ± 7.9 years. The study included all patients who were admitted to a referral center for breast radiology during 2019 - 2020 and underwent both FFDM and tomosynthesis within a short interval. The purpose of performing tomosynthesis was to assess its additional benefits over FFDM. The collected data was input into SPSS version 20 for analysis. A P-value of less than 0.05 was deemed statistically significant. Results: Out of 152 patients who initially had indeterminate findings in mammography (BI-RADS score of 0), only one patient (0.7%) remained indeterminate after tomosynthesis. This implies that tomosynthesis was able to clarify the BI-RADS scores for 99.3% of patients with previously indeterminate scores. Specifically, out of these 151 patients, 81 were scored as BI-RADS 2, 45 as BI-RADS 3, 19 as BI-RADS 4, and six as BI-RADS 5. Conclusion: Tomosynthesis has the capability to clarify unclear FFDM BI-RADS scores in over 99% of cases. This suggests that it could serve as the primary supplementary imaging technique for cases with indeterminate BI-RADS scores.
- Open Access
- 15 March 2024
- Published by Hindawi Limited in International Journal of Breast Cancer
- Vol. 2024, 1-9
Evaluation of Features in Probably Benign and Malignant Nonmass Enhancement in Breast MRI
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a highly sensitive breast imaging modality in detecting breast carcinoma. Nonmass enhancement (NME) is uniquely seen on MRI of the breast. The correlation between NME features and pathologic results has not been extensively explored. Our goal was to evaluate the characteristics of probably benign and suspicious NME lesions in MRI and determine which features are more associated with malignancy. We performed a retrospective research after approval by the hospital ethics committee on women who underwent breast MRI from March 2017 to March 2020 and identified 63 lesions of all 400 NME that were categorized as probably benign or suspicious according to the BI-RADS classification (version 2013). MRI features of NME findings including the location, size, distribution and enhancement pattern, kinetic curve, diffusion restriction, and also pathology result or 6-12-month follow-up MRI were evaluated and analyzed in each group (probably benign or suspicious NME). Vacuum-guided biopsies (VAB) were performed under mammographic or sonographic guidance and confirmed with MRI by visualization of the inserted clips. Segmental distribution and clustered ring internal enhancement were significantly associated with malignancy ( value<0.05), while linear distribution or homogeneous enhancement patterns were associated with benignity ( value <0.05). Additionally, the plateau and washout types in the dynamic curve were only seen in malignant lesions ( value <0.05). The presence of DWI restriction in NME lesions was also found to be a statistically important factor. Understanding the imaging findings of malignant NME is helpful to determine when biopsy is indicated. The correlation between NME features and pathologic results is critical in making appropriate management.- 15 March 2024
- Published by Hindawi Limited in International Journal of Breast Cancer
- Vol. 2024, 1-9
Open AccessEvaluation of Features in Probably Benign and Malignant Nonmass Enhancement in Breast MRI
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a highly sensitive breast imaging modality in detecting breast carcinoma. Nonmass enhancement (NME) is uniquely seen on MRI of the breast. The correlation between NME features and pathologic results has not been extensively explored. Our goal was to evaluate the characteristics of probably benign and suspicious NME lesions in MRI and determine which features are more associated with malignancy. We performed a retrospective research after approval by the hospital ethics committee on women who underwent breast MRI from March 2017 to March 2020 and identified 63 lesions of all 400 NME that were categorized as probably benign or suspicious according to the BI-RADS classification (version 2013). MRI features of NME findings including the location, size, distribution and enhancement pattern, kinetic curve, diffusion restriction, and also pathology result or 6-12-month follow-up MRI were evaluated and analyzed in each group (probably benign or suspicious NME). Vacuum-guided biopsies (VAB) were performed under mammographic or sonographic guidance and confirmed with MRI by visualization of the inserted clips. Segmental distribution and clustered ring internal enhancement were significantly associated with malignancy ( value<0.05), while linear distribution or homogeneous enhancement patterns were associated with benignity ( value <0.05). Additionally, the plateau and washout types in the dynamic curve were only seen in malignant lesions ( value <0.05). The presence of DWI restriction in NME lesions was also found to be a statistically important factor. Understanding the imaging findings of malignant NME is helpful to determine when biopsy is indicated. The correlation between NME features and pathologic results is critical in making appropriate management. - Open Access
- 23 October 2022
- Published by Brieflands in Iranian Journal of Radiology
- Vol. 19 (3)
Diagnostic Accuracy of Opportunistic Breast Cancer Screening Based on Mammography in Iran
Background: Although breast cancer is the most prevalent type of cancer among Iranian women, its screening is opportunistic in Iran. The available guidelines for breast cancer screening are based on mammography. A screening modality should have adequate diagnostic accuracy and be widely available at reasonable cost. Although mammography is highly accessible in Iran, its accuracy has not been investigated. Objectives: This study aimed to evaluate the accuracy of mammography in opportunistic screening regarding the current rate of patient attendance. Patients and Methods: A total of 491 women undergoing screening mammography were followed-up based on their medical records. They were divided into positive and negative screening groups, based on the breast imaging-reporting and data system (BI-RADS) categories and approaches. To evaluate the disease status of positive cases, pathology reports were investigated, and negative cases were followed-up for stability over time. Results: In the study sample, sensitivity was estimated at 73.08% (95% CI: 55.21 - 88.93), specificity was estimated at 94.41% (95% CI: 91.91 - 96.32), and accuracy was 93.28% (95% CI: 90.69 - 95.33). These test accuracy indices were not significantly different between the groups regarding age, family history, breast density, and history of breast interventions. Conclusion: The test’s sensitivity or ability to detect a disease was relatively low in opportunistic screening; it was found to be similar to the results of studies of first time implementation of screeninng. In both settings, a test needs to diagnose both incident and prevalent cases. The overall accuracy of mammography was acceptable, even in opportunistic screening.
- 23 October 2022
- Published by Brieflands in Iranian Journal of Radiology
- Vol. 19 (3)
Open AccessDiagnostic Accuracy of Opportunistic Breast Cancer Screening Based on Mammography in Iran
Background: Although breast cancer is the most prevalent type of cancer among Iranian women, its screening is opportunistic in Iran. The available guidelines for breast cancer screening are based on mammography. A screening modality should have adequate diagnostic accuracy and be widely available at reasonable cost. Although mammography is highly accessible in Iran, its accuracy has not been investigated. Objectives: This study aimed to evaluate the accuracy of mammography in opportunistic screening regarding the current rate of patient attendance. Patients and Methods: A total of 491 women undergoing screening mammography were followed-up based on their medical records. They were divided into positive and negative screening groups, based on the breast imaging-reporting and data system (BI-RADS) categories and approaches. To evaluate the disease status of positive cases, pathology reports were investigated, and negative cases were followed-up for stability over time. Results: In the study sample, sensitivity was estimated at 73.08% (95% CI: 55.21 - 88.93), specificity was estimated at 94.41% (95% CI: 91.91 - 96.32), and accuracy was 93.28% (95% CI: 90.69 - 95.33). These test accuracy indices were not significantly different between the groups regarding age, family history, breast density, and history of breast interventions. Conclusion: The test’s sensitivity or ability to detect a disease was relatively low in opportunistic screening; it was found to be similar to the results of studies of first time implementation of screeninng. In both settings, a test needs to diagnose both incident and prevalent cases. The overall accuracy of mammography was acceptable, even in opportunistic screening.
- Open Access
- 25 July 2022
- Published by Brieflands in Iranian Journal of Radiology
- Vol. 19 (2)
Successful Stereotactic-Guided Vacuum-Assisted Biopsy in the Evaluation of Breast Microcalcifications: A Study in a Single Tertiary Referral Center in the Middle East
Background: Breast microcalcifications are a category of lesions that can lead to malignancies. They remain a major concern in imaging of suspected cases. Vacuum-assisted biopsy (VAB) has been proposed as a safe and effective measure to evaluate microcalcifications. Objectives: The present study aimed to assess the results of VAB for breast microcalcifications. Patients and Methods: This cross-sectional study was conducted on patients with microcalcifications detected on mammograms. Patients were recruited through simple random sampling during 2019 - 2020, based on the inclusion criteria. The inclusion criteria were microcalcifications on mammography, classified as the breast imaging-reporting and data system (BI-RADS) categories 3, 4B, 4C, and 5, and undergoing mammography-guided VAB for the microcalcifications. Patients with missing data and those who could not be followed-up for at least six months were excluded from the study. They were assessed regarding different imaging characteristics of lesions, including the breast density, BI-RADS classification, microcalcification distribution and morphology, and other demographic and clinical features before biopsy. Additionally, the results of stereotactic-guided VAB were assessed for various benign and malignant pathologies of microcalcifications. The results of descriptive and analytical tests for various radiological and pathological features of lesions were reported. Results: A total of 257 patients, with a mean age of 50.3 ± 8.3 yars, were included in this study. Almost half of the patients (n = 125, 48.6%) had a C-grade breast composition. Regarding the BI-RADS classification, 206 (80.2%) patients were diagnosed with 4B lesions, followed by 44 (17.1%) patients with 4C lesions. The assessment of the pattern of microcalcification distribution in imaging showed that more than half of the patients (n = 148, 57.6%) had lesions in multiple groups. The most prevalent morphology of microcalcifications was punctate amorphous (n = 109, 42.4%). The majority of patients (n = 180, 70%) had benign findings in the pathological assessment, and only 69 (26.8%) had malignant features in pathology. The distribution of malignancies differed among various BI-RADS categories. In the 4B category of lesions, there were 166 benign lesions versus 32 malignant lesions, while in the 4C category, there were 10 benign lesions versus 34 malignant lesions (P < 0.001). Conclusion: This study described the findings of successful stereotactic-guided VAB for breast microcalcifications. VAB can be implemented as a promising assessment tool to evaluate suspected breast microcalcifications effectively.
- 25 July 2022
- Published by Brieflands in Iranian Journal of Radiology
- Vol. 19 (2)
Open AccessSuccessful Stereotactic-Guided Vacuum-Assisted Biopsy in the Evaluation of Breast Microcalcifications: A Study in a Single Tertiary Referral Center in the Middle East
Background: Breast microcalcifications are a category of lesions that can lead to malignancies. They remain a major concern in imaging of suspected cases. Vacuum-assisted biopsy (VAB) has been proposed as a safe and effective measure to evaluate microcalcifications. Objectives: The present study aimed to assess the results of VAB for breast microcalcifications. Patients and Methods: This cross-sectional study was conducted on patients with microcalcifications detected on mammograms. Patients were recruited through simple random sampling during 2019 - 2020, based on the inclusion criteria. The inclusion criteria were microcalcifications on mammography, classified as the breast imaging-reporting and data system (BI-RADS) categories 3, 4B, 4C, and 5, and undergoing mammography-guided VAB for the microcalcifications. Patients with missing data and those who could not be followed-up for at least six months were excluded from the study. They were assessed regarding different imaging characteristics of lesions, including the breast density, BI-RADS classification, microcalcification distribution and morphology, and other demographic and clinical features before biopsy. Additionally, the results of stereotactic-guided VAB were assessed for various benign and malignant pathologies of microcalcifications. The results of descriptive and analytical tests for various radiological and pathological features of lesions were reported. Results: A total of 257 patients, with a mean age of 50.3 ± 8.3 yars, were included in this study. Almost half of the patients (n = 125, 48.6%) had a C-grade breast composition. Regarding the BI-RADS classification, 206 (80.2%) patients were diagnosed with 4B lesions, followed by 44 (17.1%) patients with 4C lesions. The assessment of the pattern of microcalcification distribution in imaging showed that more than half of the patients (n = 148, 57.6%) had lesions in multiple groups. The most prevalent morphology of microcalcifications was punctate amorphous (n = 109, 42.4%). The majority of patients (n = 180, 70%) had benign findings in the pathological assessment, and only 69 (26.8%) had malignant features in pathology. The distribution of malignancies differed among various BI-RADS categories. In the 4B category of lesions, there were 166 benign lesions versus 32 malignant lesions, while in the 4C category, there were 10 benign lesions versus 34 malignant lesions (P < 0.001). Conclusion: This study described the findings of successful stereotactic-guided VAB for breast microcalcifications. VAB can be implemented as a promising assessment tool to evaluate suspected breast microcalcifications effectively.
- 1 March 2022
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 142, 105160
A bimodal BI-RADS-guided GoogLeNet-based CAD system for solid breast masses discrimination using transfer learning
- 1 March 2022
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 142, 105160
A bimodal BI-RADS-guided GoogLeNet-based CAD system for solid breast masses discrimination using transfer learning